Antimicrobial Multidrug Resistance: Clinical Implications for Infection Management in Critically Ill Patients
Open Access
- 16 October 2023
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 11 (10) , 2575
Abstract
The increasing incidence of antimicrobial resistance (AMR) worldwide represents a serious threat in the management of sepsis. Due to resistance to the most common antimicrobials prescribed, multidrug-resistant (MDR) pathogens have been associated with delays in adequate antimicrobial therapy leading to significant increases in mortality, along with prolonged hospital length of stay (LOS) and increases in healthcare costs. In response to MDR infections and the delay of microbiological results, broad-spectrum antibiotics are frequently used in empirical antimicrobial therapy. This can contribute to the overuse and misuse of antibiotics, further promoting the development of resistance. Multiple measures have been suggested to combat AMR. This review will focus on describing the epidemiology and trends concerning MDR pathogens. Additionally, it will explore the crucial aspects of identifying patients susceptible to MDR infections and optimizing antimicrobial drug dosing, which are both pivotal considerations in the fight against AMR. Expert commentary: The increasing AMR in ICUs worldwide makes the empirical antibiotic therapy challenging in septic patients. An AMR surveillance program together with improvements in MDR identification based on patient risk stratification and molecular rapid diagnostic tools may further help tailoring antimicrobial therapies and avoid unnecessary broad-spectrum antibiotics. Continuous infusions of antibiotics, therapeutic drug monitoring (TDM)-based dosing regimens and combination therapy may contribute to optimizing antimicrobial therapy and limiting the emergence of resistance.Keywords
This publication has 137 references indexed in Scilit:
- MRSA in Africa: Filling the Global Map of Antimicrobial ResistancePLOS ONE, 2013
- Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Combined With Antimicrobial Stewardship Team Intervention in Adult Patients With Bacteremia and CandidemiaClinical Infectious Diseases, 2013
- Matrix-Assisted Laser Desorption Ionization–Time of Flight (MALDI-TOF) Mass Spectrometry for Detection of Antibiotic Resistance Mechanisms: from Research to Routine DiagnosisClinical Microbiology Reviews, 2013
- Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patientsJournal of Antimicrobial Chemotherapy, 2010
- Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomesDiagnostic Microbiology and Infectious Disease, 2010
- Optimizing Drug Exposure to Minimize Selection of Antibiotic ResistanceClinical Infectious Diseases, 2007
- Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Cefepime pharmacodynamics in patients with extended spectrum β-lactamase (ESBL) and non-ESBL infectionsJournal of Infection, 2007
- Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2005
- Forging a Link Between Biofilms and DiseaseScience, 1999